Pilot Study on MAGE-C2 as a Potential Biomarker for Triple-Negative Breast Cancer

Figure 1

The MAGE-C2 protein expression in TNBC tissues and adjacent tissues detected by immunohistochemistry. (a and b) high MAGE-C2 protein expression in TNBC tissues; (c and d) low MAGE-C2 protein expression in TNBC tissues; (e and f) MAGE-C2 protein expression in adjacent tissues. Note: TNBC: triple-negative breast cancer.

(a)

(b)

(c)

(d)

(e)

(f)